<DOC>
	<DOC>NCT02535195</DOC>
	<brief_summary>The hypothesis of this study was that ginger supplement consumption can be introduced as a new therapeutic strategy for non-alcoholic fatty liver disease through the improved body antioxidant activity, reduced levels of inflammation and insulin resistance. A randomized double-blind study was designed to evaluate this hypothesis in order to examine the effectiveness of ginger supplement in patients with non-alcoholic fatty liver disease.</brief_summary>
	<brief_title>Effect of Ginger Supplement on Non-alcoholic Fatty Liver</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>presence of steatosis on ultrasound examination high concentration of liver enzyme (alanine aminotransferase (ALT) greater than normal range of 1.5 times) various types of hepatitis diabetes mellitus cancer inherited disorders affecting liver condition (storage disorders of iron, copper, and others) nontreated hypothyroidism using alcohol consumption of phenytoin amoxyfan and lithium using minerals multivitamin supplements such as vitamin E, vitamin D, supplements made from Silybum marianum extract like livergol weight loss surgery in the last year or strict diets to weight loss in the past three months pregnancy lactation autoimmune diseases</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>